Clinical Trial Update: Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating Oshadi D and Oshadi R for malignant mesothelioma has been suspended, with safety concerns under review.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Drugs mentioned

• Oshadi D
• Oshadi R

Snippet

Sponsor: Oshadi Drug Administration | Conditions: Mesothelioma | Phase 1, Phase 2 | Status: SUSPENDED